Literature DB >> 9046942

Infective endocarditis caused by HACEK microorganisms.

M Das1, A D Badley, F R Cockerill, J M Steckelberg, W R Wilson.   

Abstract

The HACEK group of fastidious gram-negative organisms is a recognized but unusual cause of infective endocarditis, responsible for approximately 3% of cases. We report our experience with 45 cases of endocarditis caused by HACEK organisms. In Olmsted County, Minnesota, the incidence of HACEK endocarditis was 0.14 per 100,000 person-years. In patients with native valves, 33 cases occurred, and in patients with prosthetic valves, 12 cases occurred. The most common presenting symptoms were fever, splenomegaly, new or changing murmur, and microvascular phenomena. Symptoms were present in the majority of patients anywhere from two weeks to six months prior to diagnosis. Blood cultures became positive in a mean 3.375 days, and therapy with a beta-lactam alone or as part of a combination was given for anywhere between three and six weeks. Within the first month of diagnosis, surgery was performed for 13 regurgitant valves in 11 patients (24%). Echocardiography was an insensitive predictor of subsequent major arterial embolization (odds ratio, 1.33; 95% confidence interval, 0.31-5.67). The overall survival in our cohort of patients was 87%. These results confirm previous reports that HACEK endocarditis portends a favorable prognosis.

Entities:  

Mesh:

Year:  1997        PMID: 9046942     DOI: 10.1146/annurev.med.48.1.25

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  69 in total

1.  [A 41 year-old male patient with fever of unknown origin and bacteremia with actinobacillus actinomycetemcomitans].

Authors:  S Rosenkranz; K Töpelt; H Seifert; E Erdmann; G Fätkenheuer
Journal:  Internist (Berl)       Date:  2003-09       Impact factor: 0.743

Review 2.  Need for susceptibility testing guidelines for fastidious or less-frequently isolated bacteria.

Authors:  James H Jorgensen
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

3.  Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations.

Authors:  Brian T Tsuji; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

4.  Utility of extended blood culture incubation for isolation of Haemophilus, Actinobacillus, Cardiobacterium, Eikenella, and Kingella organisms: a retrospective multicenter evaluation.

Authors:  Cathy A Petti; Hasan S Bhally; Melvin P Weinstein; Kim Joho; Teresa Wakefield; L Barth Reller; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

5.  Genetic analysis of the requirement for flp-2, tadV, and rcpB in Actinobacillus actinomycetemcomitans biofilm formation.

Authors:  B A Perez; P J Planet; S C Kachlany; M Tomich; D H Fine; D H Figurski
Journal:  J Bacteriol       Date:  2006-09       Impact factor: 3.490

6.  Leukotoxin confers beta-hemolytic activity to Actinobacillus actinomycetemcomitans.

Authors:  Nataliya V Balashova; Juan A Crosby; Lourdes Al Ghofaily; Scott C Kachlany
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

7.  Gram-negative endocarditis.

Authors:  Milagros P Reyes; Katherine C Reyes
Journal:  Curr Infect Dis Rep       Date:  2008-07       Impact factor: 3.725

8.  Evaluation of commercial universal rRNA gene PCR plus sequencing tests for identification of bacteria and fungi associated with infectious endocarditis.

Authors:  Christian Kühn; Claudia Disqué; Helge Mühl; Peter Orszag; Meike Stiesch; Axel Haverich
Journal:  J Clin Microbiol       Date:  2011-06-29       Impact factor: 5.948

9.  Cardiobacterium hominis endocarditis: A case report and review of the literature.

Authors:  Andrew Walkty
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-09       Impact factor: 2.471

10.  Acute Haemophilus parainfluenzae endocarditis: a case report.

Authors:  Leonidas Christou; Georgios Economou; Anastasia K Zikou; Kaiti Saplaoura; Maria I Argyropoulou; Epameinondas V Tsianos
Journal:  J Med Case Rep       Date:  2009-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.